Scarica l'app Stockscreener
21.17
4.23%
0.86
Pre-mercato:
26.79
5.62
+26.55%
Anaptysbio Inc Azioni (ANAB) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
20.28%
7.179
|
9.005 | 3.318 | 3.46 | 1.374 |
Operating Expenses
|
3.44%
49.38
|
51.14 | 41.05 | 43.60 | 45.77 |
| Benefits Costs and Expenses |
100.00%
-
|
180.78 | - | - | - |
| Costs And Expenses |
1.93%
49.38
|
50.35 | 41.05 | 43.60 | 45.77 |
| Operating Income/Loss |
0.16%
-42.20
|
-42.13 | -37.73 | -40.14 | -44.40 |
| Nonoperating Income/Loss |
2,069%
-1.735
|
-0.08 | 0.424 | 0.298 | 0.146 |
| Income/Loss From Continuing Operations Before Tax |
104.18%
7.179
|
-171.78 | 3.318 | -39.84 | -44.26 |
| Income/Loss From Continuing Operations After Tax |
4.09%
-43.94
|
-42.21 | -37.31 | -39.84 | -44.26 |
|
Net Income/Loss
|
4.09%
-43.94
|
-42.21 | -37.31 | -39.84 | -44.26 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
23,610%
26.80
|
-0.114 | 26.55 | 26.63 | 27.95 |
| Diluted Average Shares |
23,610%
26.80
|
-0.114 | 26.55 | 26.63 | 27.95 |
| Basic Earnings Per Share |
3.14%
-1.64
|
-1.59 | -1.41 | -1.50 | -1.58 |
| Diluted Earnings Per Share |
3.14%
-1.64
|
-1.59 | -1.41 | -1.50 | -1.58 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):